Malaria Chemotherapy

As per available reports about 31 journals, 20 Conferences, 6 workshops are presently dedicated exclusively to medicine and about 120 articles are being published on the current trends in Chemotherapy of Malaria. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to malaria are being carried out. You can take medicines in combination of anti-malarials to prevent and treat malaria. Malaria is a very serious disease, and its presence in all over world is well known. So if you are traveling to an area where malaria is present, it is important to reduce the risk of infection by taking medicine before you travel, while you are in the area, and after you return home. During malaria treatment, your doctor may do daily blood smears to follow the course of the infection. Most medicines for malaria are ones you take by mouth. But you might get intravenous (IV) medicines if there are complications or your condition gets worse. If there are no complications, your fever will clear in 36 to 48 hours. And most parasites will disappear from your blood within 2 or 3 days.

The Journal of Malaria Chemotherapy, Control & Elimination is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Chemotherapy. Each year research scientists have noticed a rise in the number of congresses being held in this field. The journal of Malaria Chemotherapy, Control & Elimination, a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Chemotherapy and thus bridging the gap between researchers and young scientists.

OMICS Group hosts over 400 leading-edge peer reviewed Open Access Journals and organize over 300 International Conferences annually all over the world. OMICS International journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities that ensure a rapid, quality and quick review process. OMICS Group signed an agreement with more than 500 International Societies to make healthcare information Open Access.